Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis

(2020) Zhen Zhou et al.   DRUGS & AGING

Muscle and statins: from toxicity to the nocebo effect

(2019) Juan Pedro-Botet et al.   Expert Opinion On Drug Safety

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies

(2019) Elena Olmastroni et al.   PHARMACOLOGICAL RESEARCH

Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy

(2018) Eliot A. Brinton   CLINICAL CARDIOLOGY

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

(2018) François Mach et al.   EUROPEAN HEART JOURNAL

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

(2018) Khoa A. Nguyen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Features Related to Statin‐Associated Muscle Symptoms

(2018) Heather M. Ochs‐Balcom et al.   MUSCLE & NERVE

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions

(2018) Peter E. Penson et al.   Journal of Cachexia Sarcopenia and Muscle

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

(2017) Ajay Gupta et al.   LANCET

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

(2016) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

Statin intolerance – a question of definition

(2016) Engi Abdel-Hady Algharably et al.   Expert Opinion On Drug Safety

Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement

(2016) Maciej Banach et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Statin-Associated Side Effects

(2016) Paul D. Thompson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Enhance placebo, avoid nocebo: How contextual factors affect physiotherapy outcomes

(2016) Marco Testa et al.   MANUAL THERAPY

Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

(2015) Maciej Banach et al.   Archives of Medical Science

A randomized trial of coenzyme Q10 in patients with confirmed Statin Myopathy

(2015) Beth A. Taylor et al.   ATHEROSCLEROSIS

Myopathy in older people receiving statin therapy: a systematic review and meta-analysis

(2015) Roli B. Iwere et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Statin intolerance

(2015) Ulrich Laufs et al.   CURRENT OPINION IN LIPIDOLOGY

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

N-of-1 (Single-Patient) Trials for Statin-Related Myalgia

(2014) Tisha R. Joy et al.   ANNALS OF INTERNAL MEDICINE

Phenotype Standardization for Statin-Induced Myotoxicity

(2014) A Alfirevic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review

(2014) YJ Chee et al.   SINGAPORE MEDICAL JOURNAL

Muscle- and skeletal-related side-effects of statins: tip of the iceberg?

(2014) Johann Auer et al.   European Journal of Preventive Cardiology

Discontinuation of Statins in Routine Care Settings

(2013) Huabing Zhang et al.   ANNALS OF INTERNAL MEDICINE

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

(2013) Melissa Y. Wei et al.   Journal of Clinical Lipidology

Prevalence and risk factors of muscle complications secondary to statins

(2011) Khalid El-Salem et al.   MUSCLE & NERVE

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings

(2009) D. Mosshammer et al.   FAMILY PRACTICE